These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions. Liu C, Desai KG. Pharm Dev Technol; 2005 Sep 10; 10(4):467-77. PubMed ID: 16370176 [Abstract] [Full Text] [Related]
32. Preparation and physicochemical characterization of a solid dispersion of (3, 5, 6-trimethylpyrazin-2-yl) methyl 3-methoxy-4-[(3, 5, 6-trimethylpyrazin-2-yl) methoxy] benzoate (VA-T) and polyvinylpyrrolidone. Cao SL, Hou P, Li B, Fu J, Yin XB, Dang XF, Yang CJ, Zhang J, Zhang H, Lei HM, Ni J. Chin J Nat Med; 2015 Nov 10; 13(11):861-866. PubMed ID: 26614461 [Abstract] [Full Text] [Related]
33. Lyophilized Amorphous Dispersion of Telmisartan in a Combined Carrier-Alkalizer System: Formulation Development and In Vivo Study. Al-Japairai KAS, Alkhalidi HM, Mahmood S, Almurisi SH, Doolaanea AA, Al-Sindi TA, Chatterjee B. ACS Omega; 2020 Dec 22; 5(50):32466-32480. PubMed ID: 33376884 [Abstract] [Full Text] [Related]
36. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability. Shuai S, Yue S, Huang Q, Wang W, Yang J, Lan K, Ye L. Eur J Drug Metab Pharmacokinet; 2016 Aug 22; 41(4):413-22. PubMed ID: 25669445 [Abstract] [Full Text] [Related]